US 2014/0371323 A1Published application

Formulations comprising 2-amino-2-[2-(4-octylphenyl)ethyl]propane-1,3-diol

AssigneeNovartis AG

InventorSupriya Rane

Life of this patent

Estimating the term…

A solid pharmaceutical composition suitable for oral administration, comprising: (a) a S1P receptor modulator; (b) a filler, and (c) a cyclodextrin.

Dependent claims

A solid pharmaceutical composition suitable for oral administration, comprising

a) a first compound selected from 2-amino-2-[2-(4-octylphenyl)ethyl]propane-1,3-diol, a pharmaceutically acceptable salt thereof, and a phosphate derivative thereof,
b) a filler, and
c) a stabilizer comprising a cyclodextrin or a derivative thereof.

Dependencies are inferred from the claim text.

A61K 31/137
Having aromatic rings , e.g. ketamine, nortriptyline: arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
A61K 9/0053
Galenical forms characterised by the site of application: mouth and digestive tract, i.e. intraoral and peroral administration
A61K 9/1652
Organic macromolecular compounds: polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
A61K 9/2013
Excipients; Inactive ingredients: organic compounds, e.g. phospholipids, fats

From the US filing history. Foreign family members aren’t listed.

Loading patent…